Children and adolescents on anti-retroviral therapy in Bulawayo, Zimbabwe: How many are virally suppressed by month six?

Background: Zimbabwe is one of the countries in sub-Saharan Africa disproportionately affected by human immunodeficiency virus. In the “treat all” era, we assessed the gaps in routine viral load (VL) monitoring at six months for children (0-9 years) and adolescents (10-19 years) newly initiated on a...

Descripción completa

Detalles Bibliográficos
Autores principales: Moyo, Silungile, Ncube, Ronald Thulani, Shewade, Hemant Deepak, Ngwenya, Solwayo, Ndebele, Wedu, Takarinda, Kudakwashe Collin, Dzangare, Janet, Goverwa-Sibanda, Tafadzwa Priscilla, Apollo, Tsitsi
Formato: Online Artículo Texto
Lenguaje:English
Publicado: F1000 Research Limited 2020
Materias:
Brief Report
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7194453/
https://www.ncbi.nlm.nih.gov/pubmed/32399206
http://dx.doi.org/10.12688/f1000research.22744.1

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7194453/
https://www.ncbi.nlm.nih.gov/pubmed/32399206
http://dx.doi.org/10.12688/f1000research.22744.1

Ejemplares similares